Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Oxidative Medicine and Cellular Longevity|May 4, 2017
Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E2 Receptor EP4 PathwayYu Ah Hong, Keum Jin Yang, So Young Jung, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 24, 2017
Regeneration of thyroid follicles from primordial cells in a murine thyroidectomized modelJunguee Lee, Shinae Yi, Joon Young Chang, et al.
Molecular Endocrinology (Baltimore, Md.)|May 10, 2003
RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1Dong Wook Kim, Jung Hwan Hwang, Jae Mi Suh, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 12, 2012
Pretreatment with paricalcitol attenuates inflammation in ischemia-reperfusion injury via the up-regulation of cyclooxygenase-2 and prostaglandin E2Hyeon Seok Hwang, Keum Jin Yang, Ki Cheol Park, et al.
Molecular Endocrinology (Baltimore, Md.)|October 2, 2004
CR6-interacting factor 1 interacts with orphan nuclear receptor Nur77 and inhibits its transactivationKi Cheol Park, Kwang-Hoon Song, Hyo Kyun Chung, et al.
The Journal of Clinical Endocrinology and Metabolism|July 20, 2006
An orally administered multitarget tyrosine kinase inhibitor, SU11248, is a novel potent inhibitor of thyroid oncogenic RET/papillary thyroid cancer kinasesDong Wook Kim, Young Suk Jo, Hye Sook Jung, et al.
Molecular Endocrinology (Baltimore, Md.)|August 7, 2004
Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinasesEun Suk Hwang, Dong Wook Kim, Jung Hwan Hwang, et al.
The Journal of Biological Chemistry|April 30, 2003
CR6-interacting factor 1 interacts with Gadd45 family proteins and modulates the cell cycleHyo Kyun Chung, Yong-Weon Yi, Neon-Cheol Jung, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2003
Gadd45gamma expression is reduced in anaplastic thyroid cancer and its reexpression results in apoptosisHyo Kyun Chung, Yong-Weon Yi, Neon-Cheol Jung, et al.
Oncogene|May 11, 2018
Loss-of-function of IFT88 determines metabolic phenotypes in thyroid cancerJunguee Lee, Shinae Yi, Minho Won, et al.
Pageof 6